Sage Therapeutics to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021

Rhea-AI Summary

Sage Therapeutics, Inc. (NASDAQ: SAGE) will host a live webcast on November 2, 2021 at 8:00 a.m. ET to announce its third quarter 2021 financial results and provide recent business updates. Access to the webcast will be available on the investor page of Sage's website, and a replay will be archived for 30 days. Sage Therapeutics focuses on developing innovative therapies aimed at transforming the treatment of brain disorders.

Positive

• Upcoming webcast to announce third quarter 2021 financial results may highlight key developments.
• Commitment to transforming lives through novel therapies for brain disorders.

Negative

• None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, November 2, 2021 at 8:00 a.m. ET to announce third quarter 2021 financial results and discuss recent business updates.

The webcast can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211020005960/en/

Investor Contact

Helen Rubinstein

315-382-3979

helen.rubinstein@sagerx.com

Media Contact

Maureen L. Suda

617-949-4289

maureen.suda@sagerx.com

Source: Sage Therapeutics, Inc.

FAQ

When will Sage Therapeutics announce its third quarter 2021 financial results?

Sage Therapeutics will announce its third quarter 2021 financial results on November 2, 2021, at 8:00 a.m. ET.

How can I access the Sage Therapeutics webcast?

The webcast can be accessed on the investor page of Sage's website at investor.sagerx.com.

Will a replay of the Sage Therapeutics webcast be available?

Yes, a replay of the webcast will be available approximately two hours after the event and archived for 30 days.

What is the focus of Sage Therapeutics?

Sage Therapeutics is focused on developing novel therapies for debilitating brain disorders.

What is the stock symbol for Sage Therapeutics?

The stock symbol for Sage Therapeutics is SAGE.